Adherence to a fixed-dose combination of rosiglitazone maleate/metformin hydrochloride in subjects with type 2 diabetes mellitus: A retrospective database analysis

Daniel R. Vanderpoel(Humana (United States)), Andrew Perry(Vanderbilt University), Teresa Watson-Heidari(Humana (United States)), Mohamed Hussein(Humana (United States))
Clinical Therapeutics
December 1, 2004
Cited by 83


Related Papers